Mikki Schantell Receives F31 NIH Fellowship Award

People with HIV have a substantially elevated risk of developing cognitive impairment despite now having a life expectancy that approaches that of the general population. Substance use disorders are also more prevalent in people with HIV, including methamphetamine use disorder, which may play a critical role in the emergence of these cognitive deficits. Graduate student Mikki Schantell, a promising young PhD student, was awarded an F31 fellowship from the National Institute on Drug Abuse in March 2022 in order to use an advanced dynamic functional brain mapping approach to identify the independent and synergistic effects of HIV-infection and methamphetamine use disorder on brain and cognitive function in adults. Ms. Schantell is a graduate student in Dr. Tony Wilson’s DICoN Laboratory at the Institute for Human Neuroscience at Boys Town National Research Hospital and the University of Nebraska Medical Center.

To learn more about Ms. Schantell’s project, please visit NIH Reporter.